// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Routine epidemiological treatment of sexual contacts of Chlamydia trachomatis, Neisseria Gonorrhoeae and infectious Syphilis - are we doing any harm?

Susannah Rennoldson - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Infants exposed to HIV and coinfection in pregnancy – the current picture using UK population level surveillance data

Helen Peters - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Hepatitis B

N/A

Using programme theory to evaluate complex sexual health interventions: evidence from the process evaluation of the LUSTRUM trial of Accelerated Partner Therapy (APT)

Fiona Mapp - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Measuring the impact of a Domestic Abuse Coordinator (DAC) in an acute trust

Eleanor Hepworth - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Howdy partner! – syphilis review in a rural countywide sexual health service

Helen Musker - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Identifying trends in STI re-infection rates

Sophie Brady - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Exploring factors that may help to stratify risk of infection in contacts of Chlamydia: is epidemiological treatment always necessary?

Jennifer Priday - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Syphilis in heterosexual individuals is rising: a local response to improve case finding

Sophie Ramsden - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Global prevalence of chlamydia, gonorrhoea and trichomoniasis in men who have sex with men: a systematic review and meta-analysis

Ella Davies - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Collaborative working to deliver a community sexual health (SH) drop-in service for trans and non-binary communities: A review of the first year

Madeleine Crow - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Are psychosocial interventions effective at increasing condom use among black men? A systematic review

Uzochi Nwaosu - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sexual behaviour and STI/HIV testing among heterosexual-identifying MSM in high-income countries: an individual participant data meta-analysis

Tyrone J Curtis - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Do we really know what’s going on - A review of child exploitation presentations to sexual health clinic

Hayley Tooley - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Meeting the complex sexual health needs of transgender men (TGM) attending an integrated sexual health clinic

Nicky Dearing - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of routine enquiry on detection rates of female genital mutilation in a sexual health clinic setting

Jennifer Davies - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Beyond the binary: how we’re failing to meet the sexual health needs of trans, non-binary and gender diverse people

Kate Ellis - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Sexual health beyond the binary: assessing transgender and non-binary individuals’ (TNB) needs and their use of online sexual health services (SHS)

Joanna Smith - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Floppy babies with anaemia

Luke Cannon - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Pritelivir: a novel treatment for multidrug resistant Herpes Simplex Virus type 2

Luke Cannon - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Herpes simplex virus infection

pritelivir

Service evaluation of GUM and HIV Clinic at an inner city category B male prison in the United Kingdom

Rebecca Marchant - British Association for Sexual Health and HIV (BASHH) , 2020

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved